Then, smaller doses keep those levels up
We understand that optimal health extends beyond just physical fitness
Weight loss expectations: In landmark trials such as STEP 1 (Semaglutide Treatment Effect in People with obesity) and SCALE (Satiety and Clinical Adiposity Liraglutide Evidence), participants achieved average weight reductions of 14.9% of initial body weight over 68 weeks with semaglutide 2.4 mg weekly, and approximately 8% with liraglutide 3.0 mg daily
Take home message Success on GLP-1 medication isn't just about the number on the scale
External resources For researchers serious about optimizing their semaglutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, personalized protocol builders, weight-based calculators, and a community of thousands who have navigated these exact dosing questions
PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., Sikiric, P